Commentator Kurt Karst is a partner with Hyman, Phelps & McNamara and blogs on pharmaceutical law and policy issues at the firm’s FDA Law Blog. His most recent post is on this subject, Patent Settlement Agreements: The Next Barrage.
Past Legal Pulse posts on “reverse payment” patent settlements include: